← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

▲ BUY
7 / 10

Conviction

$ Value

$91K

Shares

10,000

Price

$9

Filed

May 19

Why this score? (7/10)
  • Open market buy (+3)
  • Director (+1)
  • Cluster: 4 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Katkin Keith

Title

CIK

0001314596

Roles

Director

Transaction Details

Transaction Date

2025-05-19

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,000

Filing Info

Accession No.

0000950170-25-074289

Form Type

4

Issuer CIK

0001395937

Katkin Keith's History

Date Ticker Type Value
2026-02-04 SNDX A $0
2026-01-10 ELDN M $0
2026-01-10 ELDN M $0
2025-05-23 EBS $49K
2025-05-19 SNDX $91K
2025-04-30 EBS A $0
2025-04-30 EBS A $0

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$115K 2026-02-09
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04